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ABSTRACT  The epidermal  growth factor  receptor (EGF-R) on human epidermoid  carcinoma 
cells, A431, was found to be predominantly associated  with the detergent-insoluble  cytoskel- 
eton,  where  it  retained  both  a  functional  ligand-binding  domain  and  an  intrinsic  tyrosine 
kinase  activity.  The  EGF-R was  constitutively  associated  with  the  A431  cytoskeleton;  this 
association  was not a consequence  of adventitious  binding.  The EGF-R was associated  with 
cytoskeletal  elements  both  at  the  cell  surface,  within  intracellular  vesicles  mediating  the 
internalization of the hormone-receptor complex, and within lysosomes.  The EGF-R became 
more  stably associated  with  cytoskeletal  elements  after  its  internalization.  The cytoskeletal 
association  of the  EGF-R was partially disrupted  on suspension  of adherent cells,  indicating 
that alteration of cellular morphology  influences the structural association  of the EGF-R, and 
that the EGF-R is not intrinsically insoluble. 
Cytoskeletons  prepared  from  EGF-treated  A431  cells,  when  incubated  with  ,1,-32p-ATP, 
demonstrated  enhanced autophosphorylation  of the EGF-R in situ as well as the phosphory- 
lation  of  several  high  molecular  weight  proteins.  In  this  system,  phosphorylation  occurs 
between  immobilized  kinase  and  substrate.  The  EGF-R and  several  high  molecular  weight 
cytoskeletal  proteins  were  phosphorylated  on tyrosine  residues;  two of the  latter  proteins 
were phosphorylated transiently as a consequence of EGF action, suggesting that EGF caused 
the active redistribution of the protein substrates  relative to protein kinases. The ability of EGF 
to stimulate protein phosphorylation  in situ  required treatment of intact cells at physiological 
temperatures; addition of EGF directly to cytoskeletons had no effect. These data suggest that 
the structural association  of the EGF-R may play a role in cellular processing of the hormone, 
as well as in regulation of the EGF-R kinase activity and in specifying its cellular substrates. 
Epidermal growth factor (EGF),' a potent mitogen, acts on 
its target cells by first binding to cell surface receptors, initi- 
ating a  variety of changes (1) including rapid alterations in 
cell surface morphology (2, 3), cytoskeletal reorganization (4), 
and redistribution of the EGF receptors before internalization 
and degradation of the hormone (5-8). The mechanisms by 
which these changes occur, as well as those involved in the 
stimulation of DNA synthesis, are unknown. The discovery 
by Cohen and  co-workers that the  EGF receptor (EGF-R) 
possesses  an  intrinsic  tyrosine kinase  activity has  focused 
attention on the role of protein phosphorylation as a critical 
event in regulating the biological activity of this hormone (9- 
t Abbreviations  used  in  this paper.  EGF, epidermal growth factor; 
EGF-R, epidermal growth factor receptor; HMW,  high molecular 
weight. 
11). The importance of tyrosine phosphorylation, and partic- 
ularly the autophosphorylation of the EGF-R, in regulating 
cellular proliferation is not entirely clear, since the stimulation 
of DNA synthesis is reported to be dissociated from EGF- 
stimulated tyrosine kinase activity (12,  13). Nonetheless, the 
similarity  between  the  EGF-R  kinase  and  retroviral gene 
products (14-16) has stimulated the search for the cellular 
mechanisms of hormone action. 
The EGF-R is an  integral membrane protein having se- 
quence homology with the transforming gene product of the 
avian  erythroblastosis virus erb-B (17).  The EGF-R  has  a 
hormone binding domain exposed on the cell surface, while 
the protein kinase domain is located on the cytoplasmic face 
of the  membrane.  The  cellular  substrates  for the  EGF-R 
kinase have been elusive; aside from the autophosphorylated 
EGF-R, only a few proteins are phosphorylated on tyrosine 
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approach to investigating the role of protein phosphorylation 
in the mechanism of action of EGF was based on the hypoth- 
esis that hormone action is likely to produce stable changes 
in protein kinase activity and distribution relative to protein 
substrates. We have used a cell-free system which preserves 
cytoskeletal structures. In this system positional relationships 
between  structurally associated constituents of the  cell  are 
retained, with protein phosphorylation in situ occurring be- 
tween  an  immobilized  enzyme and  its  protein  substrates, 
reflecting close spatial relationships between the two (19). 
Our understanding of the mechanisms governing the orga- 
nization of proteins within biological membranes is currently 
undergoing rapid evolution. It is clear that the distribution in 
the membrane of a variety of membrane proteins is regulated 
in  part through association with structural elements of the 
cell (20-22). It has subsequently been demonstrated that for 
a variety of cells, plasma membrane proteins are linked to a 
surface lamina or structural matrix, which persists  upon re- 
moval of membrane lipids with nonionic detergents (23, 24). 
As a consequence, increasing attention has been directed at 
understanding membrane-cytoskeleton interactions and their 
role in regulating cellular architecture and metabolism (20, 
25). 
Of particular interest  is  the  involvement of cytoskeletal 
elements in mediating the aggregation and internalization of 
cell surface receptors (26-28), and their participation in elic- 
iting the biological effects  of  ligands. The cell surface receptors 
for a variety of ligands have been demonstrated to be associ- 
ated  with  the  Triton-insoluble cytoskeleton (29),  some  of 
which become associated as a consequence of ligand binding, 
e.g.,  membrane immunoglobulin (30),  nerve growth factor 
(31), and chemotactic peptide (32). Cell surface receptors for 
peptide hormones and other ligands are mobile within the 
membrane; however, on ligand binding the receptors become 
progressively immobilized, concentrating over specialized re- 
gions of the plasma membrane where they are then internal- 
ized, frequently within coated vesicles (33-37). The internal- 
ized ligand-receptor complex is then translocated through the 
cytoplasm to associate with elements of the Golgi apparatus 
and with lysosomes (38-40). What role cytoskeletal structures 
play in mediating these events is presently unclear. 
The present studies were initiated after the discovery of a 
170-kD phosphoprotein present in a cytoskeletal preparation 
of A431  cells after in situ phosphorylation. This protein has 
been identified as the EGF-R; however, its presence on the 
detergent-insoluble cytoskeleton was surprising,  since we had 
supposed this protein to be lost upon detergent solubilization 
of cellular membranes as  reported by Cooper and  Hunter 
(41). We report here that the EGF-R on A431  cells remains 
associated with the detergent-insoluble cytoskeleton both at 
the cell surface and at intracellular loci, and that the structural 
association of the  receptor may modulate the activity and 
substrate specificity of the receptor-kinase. 
MATERIALS  AND  METHODS 
Materials:  Epidermal growth factor was purchased from Collaborative 
Research  (Lexington,  MA).  Radiolabeled ATP was prepared using Gamma 
Prep A from Promega Bioteeh (Madison,  WI) and 32p~ from ICN Radiochem- 
icals  (Irvine, CA). Cellulose  thin layer  plates were from Brinkmann Instruments 
Co. (Westbury,  NY). Triton X-100 was from Sigma Chemical Co. (St. Louis, 
MO). Nonidet P-40 was from Polysciences, Inc. (Warrington, PA). 
Cell Coltore:  Human  epidermoid carcinoma cells,  A431,  were  ob- 
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tained from Dr. M. A. Bothwell. The cells were grown in Dulbecco's modified 
Eagle's medium containing 5% fetal calf serum. 
Preparation of A43 1 Cytoskeletons:  Adherent cells were grown 
in  16-mm wells, washed twice with phosphate-buffered  saline (PBS), and 0.5 
ml of the detergent-containing buffer  was  added  for  2-3  min  at 4"C; the 
resulting  cytoskeletons  were then washed briefly in detergent-free buffer. Three 
buffers were used. Buffer A contained 25 mM HEPES pH 7.4, 2 mM MnCI2, 
1 m M phenylmethylsulfonyl  fluoride, and 0.15 % or 0.5 % Triton X-100. Buffer 
B was a modification of that of Burr et al. (19) containing 1% Triton, 25 mM 
HEPES pH 7.4, 0.3 M sucrose,  100 mM KCI, 2.5 mM MgClz, 2 mM MnClz, 
1 mM CaCI2, and  1 mM phenylmethylsulfonyl  fluoride.  Buffer C was that of 
Cooper and Hunter (41) and contained 0.5% Nonidet P-40,  10 mM PIPES pH 
6.8,  100 mM KCI, 300 mM sucrose, 3 mM MgCI2, and  1 mM phenylmethyl- 
sulfonyl fluoride. 
Phosphorylation  of A431  Cytoskeletal  Proteins:  Subconflu- 
ent A431 cells were harvested from tissue culture plates and resuspended  at a 
concentration of 0.5  x  106  cells/ml in calcium- and  magnesium-free PBS 
containing 1 mg/ml each of glucose and  bovine serum albumin. EGF was 
added to the cell suspension at room temperature and at the appropriate times 
the cells were centrifuged  30 s in a  Beckman Microfuge  B (Beckman Instru- 
ments, Inc.,  Palo Alto, CA). The cell pellet was gently resuspended  in cold 
buffer A containing 0.15% Triton, and incubated 2 rain at 4"C. The resulting 
cytoskeletons were  pelleted and  resuspended  in  detergent-free  lysis  buffer, 
followed by addition of ~.-a2p-ATP (10 #M, 5.5 x  106 dpm/pmol), and incu- 
bated for  10 rain at 4"C. The phosphorylation reaction was stopped by adding 
electrophoresis  sample buffer and heating at 100*C for 5 rain. 
Phosphoamino  Acid Analysis:  The phosphoamino acid content of 
individual  32p-labeled  proteins was determined by excision of the labeled bands, 
acid hydrolysis, and separation of the labeled phosphoamino acids by electro- 
phoresis at pH 3.5 exactly as described by Cooper et al. (42). 
Binding  of 12SI-EGF to A431  Cells:  EGF was iodinated  by the 
lactoperoxidase  method (43). A431 cells were grown to near confluence  in 16- 
ram wells. The cells were washed twice with PBS followed by addition of 0.5 
ml of PBS containing t251-EGF. At the appropriate times, the t2Sl-EGF-contain- 
ing medium was removed and the cells washed three times with 1 ml of cold 
PBS,  followed by addition of 1 ml of 1 N  NaOH  to solubilize the cellular 
protein (43). Nonspecific  binding was measured in parallel incubations in the 
presence  of a  200-fold  or greater molar excess of unlabeled EGF,  and was 
routinely <10% of total binding. 
Cytoskeletaliy  associated ~251-EGF was measured as above except  that the 
second and third washes were for 30 s each at 4"C in either buffer A or buffer 
B instead of PBS. This shorter procedure  was used since Triton accelerates the 
dissociation  of ~251-EGF from its receptors (unpublished observations). The cell 
surface-bound hormone was measured by the method of Haigler et al. (44). 
The cells were washed once in PBS, incubated with 0.2 M acetic acid, 0.5 M 
NaCI for 2-5 min at 4"C, and washed briefly once more in the same buffer. 
The  washes  were  combined, and  acid-soluble  and  cell-bound  radioactivity 
determined. Over 90% of  cell surface-associated  12~I-EGF  is selectively removed 
by this procedure  (44). 
Cross-linking of ~2sI-EGF to the EGF Receptor:  Radiolabeled 
EGF was covalently coupled to the EGF-R  by the method of Comens et al. 
(45), using EGF iodinated by the Chloramine T method. A431 cells were grown 
in 16-mm we/Is and incubated for 30 min with 100 ng/ml of ~251-EGF at 37*C. 
The cells were  washed  three times with cold PBS, 0.2  ml of cold buffer  A 
containing 0.15%  Triton  was then  added,  and  the  cells  incubated for  an 
additional 2  rain  at  4°C. The  buffer  was  removed  and  the  cytoskeletons 
solubilized  in electrophoresis sample buffer. Nonspecific binding was evaluated 
by a parallel incubation including a large molar excess of unlabeled EGF.  1% 
or less of the bound ~251-EGF became covalently cross-linked  to the EGF-R. 
The amount of ~2SI-EGF-R in the various fractions was quantitated by excision 
of the labeled bands from the gels and determination of radiaoctivity in an 
LKB minigamma counter (LKB Instruments, Inc., Gaithersburg,  MD). 
Preparation of A437  Membranes and  Vesicles:  Membrane 
vesicles were prepared from A431  cells by the method of Cohen et al.  (46). 
Plasma membranes were prepared by the method of Thorn et al. (47). 
Potyacrylamide Gel Etectrophoresis:  Cellular  proteins were sep- 
arated on 4-13% polyaerylamide  gels by electrophoresis  as described  by Lae- 
mmli (48). The gels were stained with 0.1% Coomassie Blue, destained,  dried, 
and exposed  to  Kodak XAR  film with or without DuPont  Lightning Plus 
intensifying  screens (DuPont Co., Wilmington, DE). 
Phospholipid Labeling:  A431  cells were incubated in phosphate-free 
Dulbecco's modified Eagle's medium containing 50 /~Ci/ml  3zPi, for  3  h at 
37"C.  The  cells  were  washed  once with  PBS  and  extracted with buffer  A 
containing 0.15 or 0.5% Triton, or with buffer C containing 0.5% Nonidet P- 
40, for 2 rain at 4"C. The cytoskeletons were pelleted  and the phospholipids extracted three times with 1 ml of chloroform/methanol (2:1) for  1 min. The 
chloroform/methanol extracts were then combined with 0.6  ml water,  and 
twice with 0.6  ml of chloroform/methanol/water (3:48:47). The lower phase 
was collected and 32p measured by scintillation counting. 
RESULTS 
The cytoskeleton is operationally defined as those elements 
of the cell that are insoluble in nonionic detergent, including 
the surface lamina, the nucleus,  fibrous structural elements, 
and associated proteins (23, 25). 
The EGF-R was identified as a component of the detergent- 
insoluble  cytoskeleton by  covalent coupling  of 1251-EGF to 
160- and  170-kD proteins (Fig.  1). The 170-kD protein is the 
native EGF-R, a fraction of which is proteolytically degraded 
to the lower molecular weight species (49). Lysis and extrac- 
tion of the adherent A431  cells was done under a variety of 
conditions for 3  min at  4°C,  to determine  if by  increasing 
detergent concentrations and ionic strength the EGF-R could 
be solubilized (Figs.  1 and 2). 
Autoradiograms revealed  that  the  EGF-R  was  predomi- 
FIGURE  1  Association of cross-linked ~2SI-EGF-receptor complexes 
with the detergent-insoluble cytoskeleton of A431  cells. Adherent 
A431  cells were incubated with  100 ng/ml of ~2SI-EGF for 30 rain at 
37"C. The cells were extracted in buffer A containing 0.15% Triton 
(c and  f),  buffer  A  containing 0.5% Triton  (d and g},  or  buffer  C 
containing  0.5%  Nonidet  P-40  (e  and  h)  for  3  min  at  4"C.  The 
detergent-insoluble (c-e) and soluble (f-h) fractions were collected 
and  the  proteins  separated  on  4-13%  polyacrylamide  gels.  An 
autoradiogram of the ~251-EGF-receptor complexes is shown (arrow- 
head).  Nonspecific  binding of  unextracted cells incubated  in  the 
presence of a  lO0-fold  excess of unlabeled  EGF  (a). Unextracted 
cells (b). 
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FIGURE  2  Effect  of  ionic  strength 
on  the  cytoskeletal  association  of 
the  EGF-R. Adherent  A431  cells 
were  incubated with  100  ng/ml  of 
~2SI-EGF for  30  min  at  37°C.  The 
cells were then extracted for 3 rain 
at 4°C  in buffer A containing 0.5% 
Triton and the indicated concentra- 
tions  of  NaCI.  Detergent  soluble 
and  insoluble  fractions  were  col- 
lected and separated by gel electrophoresis. The labeled 12SI-EGF- 
receptor bands were excised and radioactivity determined. 
TABLE  I.  Effect of A431  Membrane Vesicle Protein on 
Cytoskeletally Associated 12~I-EGF 
1251_EG  F 
0.15% Triton 
Total  insoluble 
cpm 
Control  11,684  10,117 
100 #g/ml Vesicle protein  9,520 
200 #g/ml Vesicle protein  9,780 
A431 cells were incubated with  2 ng/ml 12SI-EGF for  15  rain at 37°C. The 
cells were washed three times with  PBS for determination of total binding. 
Cytoskeletally associated 12SI-EGF was measured by first washing the cells 
once with  PBS followed  by two washes at 4°C  with  buffer A  containing 
0.15% Triton X-100. Membrane vesicles  prepared from A431 cells were lysed 
in buffer A containing 0.15% Triton X-100 and adjusted to 100 or 200 ug of 
vesicle protein per milliliter.  The cells were lysed  at 4"C for 1 rain with 0.5 
ml of this solution containing vesicle protein, washed once with  buffer A, 
and cytoskeletally associated radioactivity was determined. The EGF-R con- 
tent of the vesicles was approximately 5- and 10-fold greater, respectively, 
than the amount of EGF-R present in the A431 cells in the assay. 
nantly associated with the detergent-insoluble cytoskeleton, 
whether buffer A containing 0.15%  or 0.5%  Triton was used 
(Fig.  1). In a series of three experiments, extraction of A43 l 
cells with 0.15  or 0.5%  Triton solubilized from  12-17%  and 
20-35%  of the EGF-R,  respectively. Increasing the salt con- 
centration to as much as 0.5  M  resulted in solubilization of 
only an additional  15%  of the EGF-R from the cytoskeleton 
(Fig. 2). Extraction in the buffer of Cooper and Hunter (buffer 
C) under these conditons solubilized -50%  of the EGF-R. 
We compared the efficiency of lipid removal in the various 
buffer  systems by  labeling  cellular  phospholipids  with  32p. 
Triton  in  buffer A  at  concentrations of 0.15  and 0.5%  re- 
moved 62 and 77%,  respectively, of 32p-labeled  lipids. Buffer 
C, containing 0.5%  Nonidet P-40, solubilized 89% of cellular 
phospholipids; this buffer was also more efficient in solubi- 
lizing cellular proteins, resulting in the loss of 42% of cellular 
protein, while buffer A  containing 0.15%  Triton solubilized 
33%. 
Cytoskeletal Association of the EGF-R Was Not 
Due to Adventitious  Binding 
A concern in these experiments was that the association of 
the EGF-R with the cytoskeleton may have been the result of 
adventitious binding of the solubilized EGF-R to cytoskeletal 
elements at the moment of cell lysis. We tested whether the 
EGF-R became nonspecifically associated with the cytoskel- 
eton by  lysing the cells in the presence of a  large excess of 
plasma membrane protein which included the EGF-R (Table 
I).  The  presence  of a  large  molar excess  of EGF-R  at  the 
moment of cellular lysis had no effect on the amount of 125I- 
LANORETH ET AL.  Cytoskeletal Associ~]tion  of the EGF-R  1343 EGF  associated  with  the  cytoskeleton,  suggesting  that  the 
EGF-R  was  not  adventitiously bound  to  the  cytoskeleton; 
rather, it was structurally associated at the time of cell lysis, 
and remained so even in the presence of an excess of soluble 
EGF-R. If  the association of the EGF-R with the cytoskeleton 
was artifactual, then we would have expected a diminution of 
cytoskeletally associated ~25I-EGF, due to occupancy of non- 
specific cytoskeletal binding sites by exogenous EGF-R and 
other membrane proteins. 
A  second  series  of experiments  was  performed  to  test 
whether  soluble  tzSI-EGF-R  would  bind  to  A431  cytoskel- 
etons. Radiolabeled EGF was cross-linked to EGF-R in puri- 
fied  membranes,  and  the  uncross-linked  ~25I-EGF was  re- 
moved  by  addition  of an  excess  of unlabeled  EGF.  The 
membranes were solubilized as described by Cohen (49) and 
then the solubilized  ~2SI-EGF-receptor complex collected by 
centrifugation. A431  cells were lysed in buffer A containing 
0.15 % Triton and 2,000,  5,000 or l 0,000 cpm of soluble t25I- 
EGF-receptor. Under these conditions,  only ~3%  (60,  152, 
and 255 cpm, respectively) of the soluble ~25I-EGF-R  became 
associated with the A431  cytoskeletons. These data indicate 
that solubilized EGF-R does not bind to the cytoskeletons, 
and that the structural association of the EGF-R was not an 
artifact of the detergent-solubilization procedure. 
Cytoskeletally Associated EGF-R Retains an EGF- 
stimulated Tyrosine  Kinase Activity 
The EGF-R that was retained with the detergent-insoluble 
cytoskeleton  possessed an  EGF-stimulated  tyrosine-specific 
protein kinase activity. When A431 cells are treated with EGF 
in vivo, the EGF-R undergoes extensive EGF-stimulated au- 
tophosphorylation in  situ  (Fig.  3A).  In addition,  the  phos- 
phorylation of several high molecular weight (HMW) cyto- 
skeletally associated proteins was stimulated as a consequence 
of EGF treatment. Stimulation of the cells with EGF results 
in a 50-100% increase in EGF-R autophosphorylation in situ; 
this value is  somewhat less  than  that  observed for isolated 
membranes or soluble EGF-R preparations (9, 46, 48). Max- 
imal stimulation of EGF-R autophosphorylation occurred at 
EGF concentrations of 50 ng/mi. 
The phosphorylation reaction occurs between immobilized 
protein kinase and protein substrates positioned in proximity 
to the active enzyme (19).  Little or no protein kinase activity 
could  be  detected  in  solution  during  the  phosphorylation 
reaction (Fig. 3B). 
Binding of 1251-EGF to A43 1 Cells 
and Cytoskeletons 
The discovery that the  EGF-R was associated with cyto- 
skeletal elements led us to question whether the association 
FIGURE  3  EGF-stimulated  phosphorylation  of  A431  cytoskeletal 
proteins in situ. (A) A431  cells were incubated for 5 min at 22°C in 
the absence (a and c) or presence (b and d) of 50 ng]ml EGF. The 
cells were lysed in  buffer A  containing 0.15% Triton  for 2  min at 
4°C. The resulting cytoskeletons were pelleted and resuspended in 
buffer A containing 10 #M 3,-32P-ATP  for 10 min at 4°C. The labeled 
proteins were separated on 4-13%  polyacrylamide gels.  An auto- 
radiogram of the labeled proteins is shown after an exposure of ~6 
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h (a and b) or 24 h (c and d). (B) A431  cells were incubated with 50 
ng/ml  EGF for 5  min at 22°C,  lysed in  buffer A  containing 0.15% 
Triton, and the  resulting cytoskeletons resuspended in  detergent- 
free  lysis  buffer.  Both  the  cellular  lysate and  cytoskeletons were 
incubated  with  "l,-32P-ATP for  10  min  at  4°C.  The  cytoskeletons 
were then pelleted by centrifugation and the reaction supernatant 
recovered. The samples were separated on 4-13% polyacrylamide 
gels. Coomassie Blue-stained proteins (a-c) and the corresponding 
autoradiograms (d-f)  of the cellular lysate (a and d), cytoskeletons 
(b and e), and reaction supernatant (c and f) are shown. The position 
of the EGF-R is indicated. changed with  cellular processing and internalization  of the 
EGF-R complex, or under  conditions where the  EGF-R is 
mobile within the plane of the plasma membrane. 
After binding of '25I-EGF to A431  cells at 22"C,  the  '25I- 
EGF remained predominantly associated with the cytoskel- 
eton on extraction of  the cells with 0.15% Triton or 1% Triton 
at higher ionic strength (Fig.  4).  The latter buffer has previ- 
ously been  demonstrated  to  preserve cytoskeletal structure 
(except microtubules) (19). 
If the binding was performed at 4"C,  similar results were 
obtained.  Although  the total amount of ~2~I-EGF bound at 
this temperature was lower than  that at  37"C,  most of the 
specifically bound ~25I-EGF  was associated with the cytoskel- 
eton. At low temperature, EGF-R complexes remain mobile 
as measured by the lateral diffusion coefficient, yet the con- 
centration of receptors over coated pits and internalization 
are arrested (5, 7, 37). These data indicated that although the 
EGF-R could translocate within the membrane, it was asso- 
ciated with cytoskeletal elements of the cell. Similar data were 
obtained using 1251-EGF concentrations ranging from 1-100 
ng/ml. 
Whether the EGF-R was constitutively associated with the 
A431  cytoskeleton, or rather became associated with it as a 
consequence of receptor occupancy, was tested by preparing 
cytoskeletons from untreated A431  cells and measuring the 
ability of the cytoskeletal preparations to specifically bind '2~I- 
EGF (Fig.  5).  Radiolabeled EGF was specifically bound to 
the A431 cytoskeleton, indicating that the EGF-R was consti- 
tutively associated with the detergent-insoluble cytoskeleton, 
where it retained a functional ligand-binding domain. 
We have frequently been able to bind 125I-EGF  to cytoskel- 
etons at levels comparable to those of intact cells;  however, 
varying the time of the solubilization step, inclusion of phos- 
phatase  inhibitors  or  ATP  in  the  lysis  buffer  or  binding 
solution all affect the degree of receptor binding in the cyto- 
skeletal preparation (unpublished observations). These effects 
are likely to be related to modulation of the phosphorylation 
state of the EGF-R. The phosphorylation state of the receptor 
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FIGURE  4  ~251-EGF binding  to  A431  cells.  A431  cells  were  incu- 
bated with ~zSI-EGF (5 ng/ml} at 22°C (A) or4°C (B). At the indicated 
times, the ~2SI-EGF-containing medium was aspirated and the cells 
washed with PBS. The cells were then washed twice more with PBS 
(O), buffer A containing 0.15% Triton (©), or buffer B containing 1% 
Triton (&), and the bound radioactivity determined. The points are 
the mean of duplicate determinations, which routinely differed by 
<5%. The data have been corrected for nonspecific binding, which 
was normally <10% of total binding. 
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FIGURE  5  Binding of  '251-EGF to A431  cytoskeletons. A431  cells 
grown in  16-ram wells were lysed by two washes at 4°C in buffer 
A  containing 0.15% Triton,  and then washed twice  in detergent- 
free buffer A. The cytoskeletons were then incubated with 2 ng/ml 
12SI-EGF for the indicated periods at 37°C,  followed by two addi- 
tional  washes  in  cold  buffer  A  (O). Nonspecific  binding  (O)  was 
determined in a  parallel incubation  in the presence of a 500-fold 
molar excess of unlabeled EGF. 
has a significant effect on receptor affinity and its ability to 
undergo ligand-stimulated autophosphorylation (50,  51). 
The EGF-R Is Associated with the Cytoskeleton  at 
tntracellular  Loci 
The observation that the EGF-R was associated with the 
cytoskeleton after several minutes at 37"C suggested that the 
EGF-R retained  its association  with  the  cytoskeleton after 
internalization. Haigler et al. (5) reported that on binding of 
EGF to A431  cells at 4"C, followed by removal of unbound 
ligand and incubation at 37"C, the EGF associated with the 
cell surface was rapidly internalized, appearing in cytoplasmic 
vesicles within  3 min. After 30 min at 37"C,  -80% of cell- 
associated EGF was located within lysosomes. 
Using an experimental protocol similar to that of Haigler 
et al.  (5),  we  found  that  EGF was rapidly internalized,  as 
indicated by the rapid loss of acid-soluble radioactivity (Fig. 
6). However, the ~2SI-EGF-receptor  complex remained asso- 
ciated with  the Triton-insoluble cytoskeleton even at times 
when the EGF was predominantly located within lysosomes. 
These data demonstrate that the EGF-R was associated with 
cytoskeletal elements at the cell  surface and at intracellular 
loci after its internalization. 
The  same experiment was  repeated except that  the  ~2sI- 
EGF was added at a concentration of 100 ng/ml, permitting 
the detection of ~2SI-EGF  cross-linked to the EGF-R (Fig. 7). 
The  125I-EGF-receptor complex  was  nearly  quantitatively 
associated with  the cytoskeleton on  extraction  with  0.15% 
Triton or in 0.5% Nonidet P-40 in buffer C. Significantly, the 
degree of solubility of the  EGF-R in  buffer C  under these 
conditions was substantially less than that shown  in  Fig.  1 
(17%  as compared with  50%),  indicating that  intracellular 
EGF-R was more stably associated with the cytoskeleton than 
was EGF-R on the cell surface. This change may be related 
to the recent report that the conformation of the EGF-R is 
LANDRETH lET AL.  CytoskeletalAssociation  of the ECF-R  ] 345 2O 
Io 
o°'E  15 
,0 
w 
i  o 
~  5  A 
~  v  v  v  v  v 
2  3  4  5  6 
TIME (hours) 
FIGURE  6  Redistribution of ]251-EGF on A431  cells at physiological 
temperatures. A431  cells were incubated with 5 ng/ml ]2SI-EGF for 
40 min at 4°C, washed twice in PBS, and then warmed to 37°C. At 
the  indicated  times,  the  cells  were  washed  once  with  PBS, then 
twice  with  PBS  (©),  buffer A  containing 0.15% Triton  (I),  or with 
0.2 M  acetic acid, 0.5 M  NaCI. The cell-associated and acid soluble 
(A) radioactivity was then measured. Nonspecific binding was <10% 
of total binding and has been subtracted. 
altered upon its internalization in the endocytic vesicles (52). 
This experiment convincingly illustrates that very little solu- 
bilization of the EGF-receptor complex occurred upon deter- 
gent treatment of adherent A431  cells.  The intracellular lo- 
cation of the  12~I-EGF-R was verified by incubating parallel 
samples at 4°C in the presence of 0.5 mg/ml trypsin. The ~25I- 
EGF-receptor complex was resistant to the  proteinase.  We 
concluded from these experiments that the EGF-R complex 
was cytoskeletally associated at intracellular loci, both within 
the  cytoplasmic vesicles mediating hormone internalization 
and within lysosomes. 
To  verify that  the  cytoskeletally associated  EGF-R  was 
present within  lysosomes, A431  cells  were treated with  the 
lysosomotropic agent  chloroquine  (Table  II).  Chloroquine 
inhibits  the  degradation  of  '25I-EGF without  affecting  its 
internalization (53).  Chloroquine-treated cells contained sig- 
nificantly greater amounts of '25I-EGF, which was predomi- 
nantly associated with the cytoskeleton, compared with un- 
treated cells. These data demonstrate that EGF-receptor com- 
plexes remained associated with the cytoskeleton within intact 
lysosomes. The increase in amount of lysosomal EGF-R was 
not as great as that observed in fibroblasts (53), but is consist- 
ent with the observation that these cells do not down-regulate 
their  receptors  as  efficiently (54,  55).  It was  possible  that 
lysosomes were resistant to  detergent at the  concentrations 
used,  resulting  in  the  artifactual  retention  of labeled  EGF 
within membrane-bounded compartments. This was shown 
to be unlikely as the lysis of the cells  in 0.15  or  1% Triton 
resulted  in  the  solubilization  of >90%  of lysosomal  acid 
phosphatase (data not shown). 
Solubilization of the EGF-R from A431  Cells 
in Suspension 
We investigated whether other dramatic changes in cellular 
morphology  might  affect the  structural  association  of the 
EGF-R. A431 cells were brought into suspension by treatment 
with 5 mM EDTA in calcium- and magnesium-free PBS. The 
resuspended cells were rounded,  in contrast to the flattened 
and tightly adherent cells used in previous experiments. The 
EGF-R from cells in suspension, unlike adherent cells, were 
partially (30-50% of total EGF-R) solubilized upon treatment 
with 0.15% Triton (Fig. 8). 
Two important conclusions can be drawn from this exper- 
iment.  The  data  demonstrated  that  by  removing  the  flat, 
FIGURE  7  The  EGF-R  is  cytoskeletally associated  at  intracellular 
loci. A431  cells were incubated with  100 ng/ml ]2SI-EGF for 40 min 
at 4°C,  and  the cells  washed twice  to  remove the  unbound  1251- 
EGF.  The cells were warmed to  37°C  and  incubated at that tem- 
perature for  15  min.  Whole  cells  were  collected  (b),  or the cells 
extracted with two washes in buffer A containing 0.15% Triton and 
the detergent-insoluble cytoskeletal fraction  (c) or detergent-solu- 
ble fraction (d) were collected. After 30 min of incubation at 37°C, 
unextracted cells (f), cytoskeletal (g), and soluble (h) fractions from 
cells extracted in buffer A with 0.15% Triton, or cytoskeletal (i) and 
soluble (j) fractions from cells extracted in buffer C, were collected. 
The  ~2SI-EGF-receptor  complexes were determined to be internal- 
ized as indicated  by trypsin  resistance. After  15  min  (e) or 30 min 
(k) at 37°C the cells were cooled to 4°C and incubated an additional 
30 min with 0.5 mg/ml trypsin.  Nonspecific  binding was measured 
(a) in a  parallel incubation  in the presence of a  100-fold excess of 
unlabeled EGF followed by a 30-min incubation at 37°C. An auto- 
radiogram of the lzSI-EGF-receptor complexes is shown. 
TABLE II.  Effect of Chloroquine on ~2SI-EGF  Binding to A431  Cells 
~zSI-EGF (cpm) 
Cytoskele- 
tally associ-  Cell sur- 
Total  ated  face 
Untreated  12,675  10,200  1,800 
0.1  mM Chloroquine  16,490  13,230  1,610 
A431  cells were preincubated for 30 min at 37°C with 0.1  mM chloroquine, 
followed  by  incubation  for  40  min  at  4°C  with  5  ng/ml  lzSI-EGF. The 
radiolabeled  EGF was  removed, and the cells  were washed twice with  PBS 
and  incubated  for  3  h  at  37°C  in  the  presence  or  absence  of  0.1  mM 
chloroquine,  and washed with  PBS. Total  ~zSI-EGF binding was determined 
after two further washes with PBS. Cytoskeletal binding was measured  after 
two  additional  washes  at  4*C  in  buffer  A  containing  0.15%  Triton.  Cell 
surface-associated  EGF was measured  by treating the cells with 0.2 M acetic 
acid  and 0.5 M  NaCI  for 2 min at 4°C, removing all  cell  surface-associated 
EGF.  Nonspecific  binding  was  measured  in  a  parallel  incubation  in  the 
presence  of 1 /~g/ml unlabeled EGF and has been subtracted from the data. 
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tion). 
Whereas EGF treatment of A431  cells at 22"C  stimulated 
the  autophosphorylation of the  EGF-R by  50-100%  if the 
reaction was carried out at 4"C, little or no (0-20%) stimula- 
tion of EGF-R autophosphorylation was observed (Roy, L., 
S. Alam, and G. Landreth, manuscript in preparation). These 
data indicate that the activation of the cytoskeletally associ- 
ated EGF-R requires treatment of intact A431  cells at physi- 
ological temperatures, suggesting that ligand occupancy alone 
is not sufficient to activate the structurally associated receptor- 
kinase in situ. 
Time Course of EGF-stimulated Phosphorylation 
of Cytoskeletal Proteins 
A431  cells were treated with EGF (50 ng/ml) at 22"C  for 
30 s to 20 min, cytoskeletons prepared, and then incubated 
for 10 min with .y-a2p-ATP. EGF stimulated the phosphoryl- 
ation of several HMW cytoskeletal proteins in addition to the 
autophosphorylation of the EGF-R (Fig.  9). The phosphory- 
lation in situ of two of these proteins had distinctly different 
FIGURE  8  Solubilization of the EGF-R from A431  cells in suspen- 
sion. A431  cells were left adherent to tissue culture wells (d and e), 
or brought into suspension (a-c) by incubation with 5 mM EDTA in 
calcium-  and  magnesium-free PBS  and  resuspension  in the same 
buffer without EDTA.  12SI-EGF (50 ngJml) was added and the cells 
incubated for 30 min at 37°C in the presence (a) or absence (b and 
d) of 1 #g/ml unlabeled EGF. The cells were pelleted, resuspended 
in  buffer  A  containing 0.15%  Triton,  and  incubated  for  2  min  at 
4°C.  Cytoskeletal and soluble fractions were recovered after cen- 
trifugation and separated by gel electrophoresis. An autoradiogram 
of the  1251-EGF-receptor  complexes is shown  and  the  position  of 
the EGF-R indicated. 
adherent cells from their substratum, the association of the 
EGF-R  with  the  cytoskeleton  was  partially  disrupted  as  a 
consequence  of the altered cytoskeletal organization  in  the 
unattached, rounded cells. Further, the observation that under 
some conditions  the  EGF-R  can  become detergent-soluble 
provides additional evidence that the association of the EGF- 
R  with  the  cytoskeleton is  neither the  result  of artifactual 
binding due to detergent treatment, nor due to an inherent 
insolubility of the receptor. We have been unable to demon- 
strate that calcium plays a significant role, since the addition 
of either calcium or EGTA to the lysis buffer had no effect 
on  the  association  of the  EGF-R with  the  cytoskeleton in 
adherent cells (data not shown). 
Stimulation of the Cytoskeletally Associated EGF- 
Receptor Kinase Requires Treatment of Intact 
Cells at Physiological Temperatures 
The ability of EGF to stimulate the  autophosphorylation 
of the  EGF-R present on  cytoskeletons prepared from un- 
treated A431  cells was tested. Addition of EGF ( 100-200 ng/ 
ml)  directly  to  A431  cytoskeletons  failed  in  all  cases  (six 
experiments) to stimulate the  incorporation of 32p into  the 
EGF-R when  incubated  either at 4* or 22"C  for 5-15  rain 
FIGURE  9  Time course of EGF-stimulated phosphorylation of cy- 
toskeletal proteins in situ. A431  cells were incubated with EGF (50 
nglml) for 30 s-20 min at 22°C, cytoskeletons prepared using buffer 
A  with  0.15% Triton,  and  then  incubated  with  ~,-[32P]ATP for  10 
min at 4°C. Autoradiograms of the labeled cytoskeletal proteins are 
shown from untreated cells (a); and from cells exposed to EGF for 
30 s (b), and 1 (c), 2 (d), 5 (e), 10 (f), and 20 (g) rain. The approximate 
molecular weights of  the  responsive  proteins were  330  and  300 
kD. 
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transient,  with  enhanced  labeling occurring  within  30  s  of 
hormone exposure and disappearing after 5 min with EGF. 
The phosphorylation of a  300-kD protein is much different; 
this protein becomes labeled within 5 min of EGF exposure 
and does not diminish until after 20 min with EGF. The time 
dependence of 32p-labeling  of the EGF-R demonstrates that 
the EGF-R kinase activity is persistent throughout the entire 
period, with little difference in receptor autophosphorylation 
between short and long exposures to EGF. These data dem- 
onstrate that not only are other cytoskeletal proteins substrates 
for EGF-stimulated protein kinase activity, but the availability 
of the protein substrates to the hormonally stimulated kinase 
changes rapidly as a consequence of hormone action. 
Phosphoamino Acid Analysis of 
C)/toskeletal Phosphoproteins 
The HMW cytoskeletal proteins whose phosphorylation in 
situ  was  enhanced  by  EGF  treatment  of A431  cells  were 
excised  from the  gel,  hydrolyzed, and  their phosphoamino 
acid  composition determined.  The  HMW cytoskeletal pro- 
teins possessed phosphotyrosine as well as phosphoserine and 
phosphothreonine residues (Fig.  10; Table III). The amount 
of phosphotyrosine in these proteins varied between 24-50% 
of total  protein  phosphate.  The  relative  rarity  of tyrosine 
kinases  other than  the  EGF-R  in  these  cells  indicates  the 
involvement of the EGF-R in the phosphorylation of these 
proteins. The presence of phosphoserine residues suggests that 
these proteins are also substrates for other cytoskeletally as- 
sociated protein kinases. The EGF-R appears to be labeled 
FJGURE  10  Pbosphoamino acid analysis of A431  cytoskeletal pro- 
teins. The radiolabeled cytoskeletal proteins from  untreated A431 
cells (a) or cells treated for 5 min at 22°C with  50 ng/ml  EGF were 
phosphorylated in  situ  and  separated on  5-15%  polyacrylamide 
gels. Those proteins whose phosphorylation was stimulated by EGF 
treatment are shown  in  Fig. 9;  these bands were excised, hydro- 
lyzed, and  the phosphoamino acids separated by electrophoresis 
on a thin-layer plate at  pH  3.5;  (a)  EGF-R, basal;  (b)  EGF-R,  EGF- 
stimulated;  (c)  200-,  (d)  250-,  (e)  300-,  (f)  330-,  and  (g)  360-kD 
cytoskeletal proteins. The positions of phosphoamino acid  stand- 
ards are shown. 
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TAmE  III.  Phosphoamino Acid Composition  of A431 Cytoskeletal 
Proteins 
Protein  P-Ser  P-Thr  P-Tyr 
kD  %  %  % 
360  53  19  28 
330  37  23  40 
300  42  35  23 
25O  57  19  24 
200  34  16  50 
EGF-R (basal)  12  5  83 
EGF-R (stimulated)  9  8  83 
A431 cells  were incubated in the absence or presence of 100 ng/ml of EGF 
for 5 min at 22°C, cytoskeletons prepared and incubated with  10 #M 3,-32P  - 
ATP for 15 rnin at 4°C. The cytoskeletal proteins were separated on 4-13% 
SDS polyacrylamide gels, stained, dried, and autoradiograms obtained. Cy- 
toskeletal proteins whose phosphorylation was stimulated by EGF are indi- 
cated in Fig. 9; these proteins were excised from the gel and hydro[yzed, 
and phosphoamino acids were separated. The labeled phosphoamino acids 
were scraped i:rom the thin layer plates, and radioactivity was determined. 
The data are expressed as the  percentage of radioactivity associated with 
each amino acid. 
almost exclusively on tyrosine residues, which  is consistent 
with other observations on the  in  vitro phosphorylation of 
this  protein  (I 1);  however,  we  detected  small  amounts  of 
labeled phosphoserine and phosphothreonine  residues,  sug- 
gesting that  the  EGF-R  may also be  a  substrate  for other 
protein  kinases in  situ.  We have not  ruled  out  that  other 
phosphoproteins  may  have  co-migrated  with  the  EGF-R, 
which might account for the presence of phosphoserine and 
phosphothreonine residues. 
DISCUSSION 
We report here that the EGF-R on A431  cells is constitutively 
associated with the detergent-insoluble cyloskeleton, where it 
retains an active ligand-binding activity and tyrosine-specific 
protein kinase activity. 
The present studies were initiated in an attempt to deter- 
mine whether EGF produced stable alterations in A431  cells 
which  persisted in  the  detergent-insoluble  cytoskeleton,  re- 
sulting in changes in phosphorylation of cytoskeletally asso- 
ciated proteins in situ, analogous to those observed on hor- 
mone treatment of PC12 cells (56). We were surprised to find 
that the  major phosphorylated species present in  the  cyto- 
skeletons was the EGF-R, since we had anticipated that the 
detergent treatment would result in  the  loss of this integral 
membrane protein, as reported by Cooper and Hunter (41). 
It is possible that in the experiments of Cooper and Hunter, 
where the EGF-R was detected by immunoprecipitation, that 
the EGF-R in particulate fractions was not detected due to 
incomplete solubilization of the receptor from the cytoskel- 
eton (41). 
The relative insolubility of the EGF-R was noted by Linsley 
and Fox (57), who reported that on treatment of A431  mem- 
branes with Triton at concentrations up to 10%, -50% of the 
EGF-R was sedimented after low-speed centrifugation; more- 
over, treatment of the membranes with sodium dodecyl sul- 
fate,  urea,  or  high  salt concentrations  failed to  completely 
solubilize the  EGF-R. The  EGF-R,  once solubilized,  has a 
heterogeneous  size  distribution,  eluting  on  gel  filtration  at 
positions well ahead of that expected of the  170-kD EGF-R 
(49,  57). 
The persistent association of the EGF-R with the detergent- 
insoluble cytoskeleton suggests that the EGF-R interacts with 
components of the surface lamina, rendering it insoluble. The data argue that this interaction is a specific one of importance 
in  the  processing of the  hormone-receptor complex.  First, 
disorganization of cellular morphology on suspension of the 
cells results in the solubilization of ~30-50% of the EGF-R. 
This is likely to be related to the twofold reduction in the rate 
of EGF internalization  and  degradation  by the  suspended 
cells compared with adherent ones (7). Second, the interaction 
of the  EGF-R with  cytoskeletal elements is stabilized after 
internalization of  the hormone-receptor complex as indicated 
by the decrease in EGF-R solubility in buffer C  after inter- 
nalization (Figs.  1 and 7). We interpret these data as evidence 
that the EGF-R at the cell surface interacts with components 
of the surface lamina, even under conditions where the recep- 
tor has been demonstrated to be mobile. These observations 
suggest that the EGF-R may interact with structural elements, 
perhaps transiently. These types of interactions may account 
for the diminished diffusion coefficients of proteins in biolog- 
ical  membranes compared with  pure phospholipid bilayers 
(7, 36,  37,  58,  59).  These structural interactions of the EGF- 
R may also be involved in the vectorial movement of occupied 
receptors to internalization sites and then directing the move- 
ment between intracellular organelles. One striking finding in 
this study was that the EGF-R retained its cytoskeletal asso- 
ciation after internalization and translocation to various in- 
tracellular loci including  lysosomes. We had supposed that 
these intracellular vesicles and their contents would be lost 
on detergent treatment. These observations suggest  that the 
protein  matrix  constituting  the  surface lamina  may be  re- 
tained as a  component of the endocytotic vesicle,  and may 
indicate that intracellular membranous systems also possess 
such a structural matrix as a constituent of their membranes. 
It is not unreasonable that a structural matrix and associated 
proteins may specify not only characteristic morphology of 
intracellular membranous compartments, but also may play 
a central role in establishing the biochemical individuality of 
these membranes (60,  61). 
The association of the EGF-R with the cytoskeleton is not 
likely to involve cellular microtubules or microfilaments since 
treatment of A431  cells with either 50 uM colchicine or  10 
uM  cytochalasin D  has no effect on the association of the 
EGF-R  with  the  cytoskeleton.  Furthermore,  incubation  of 
~25I-EGF-labeled  cytoskeletons  with  DNase  I  was  without 
effect (data not shown). 
We have investigated EGF-stimulated protein phosphory- 
lation using a cell-free system in which structural relationships 
are preserved (19, 62).  The in situ phosphorylation observed 
in this preparation reflects the activity of a structurally asso- 
ciated enzyme acting on protein substrates that are also im- 
mobilized,  and implies that close spatial relationships exist 
between the two species. The ability to detect EGF-stimulated 
phosphorylation of cytoskeletal proteins is likely to be due in 
part  to the  loss of active phosphoprotein phosphatases on 
removal of cellular membranes and soluble proteins. The use 
of this system has allowed us to discern subtle rearrangements 
of proteins relative to the respective kinases (or vice versa), 
and had validated this approach to investigation of hormone 
action,  since we have demonstrated that  EGF does indeed 
produce stable changes that persist in the detergent-insoluble 
cytoskeleton. The evanescent phosphorylation of the HMW 
cytoskeletal  proteins  suggests  that  on  ligand  binding  and 
activation of the EGF-R kinase, structural relationships are 
changed such that the HMW proteins become accessible to 
the kinase as a transient consequence of hormone action. The 
tyrosine kinase activity in these cells is due almost entirely to 
the EGF-R as a  result of amplification of the EGF-R gene 
(63). 
We have chosen to use A431  cells in suspension for phos- 
phorylation studies principally because we could reproducibly 
demonstrate EGF-stimulated protein phosphorylation in this 
preparation.  Similar studies with  adherent cells  have given 
inconsistent results, due mainly to very high basal levels of 
EGF-R autophosphorylation in situ. 
The fidelity with which this system reflects the situation in 
vivo is unclear, given the relaxed specificity of protein phos- 
phorylation in vitro (42).  The advantage of this preparation 
is that it allows identification of putative protein substrates of 
the EGF-R, since these proteins lie in proximity to the kinase. 
Indeed, using this rationale, the HMW cytoskeletal proteins 
have been shown to be phosphorylated in vivo, and we are 
currently attempting to identify the labeled residues. 
The HMW  cytoskeletal proteins were also substrates for 
other kinases, resulting in the in situ phosphorylation at serine 
and threonine residues. Whether EGF stimulates the activity 
of a separate class of kinases in situ is unclear. However, in 
vivo protein phosphorylation on these residues is enhanced 
by EGF treatment, including phosphorylation of the EGF-R 
(15,  50). 
The inability of A431  cells treated with EGF at low tem- 
perature to undergo EGF-stimulated receptor autophosphor- 
ylation in situ was an unexpected observation, and suggests 
that  cellular events occurring at elevated temperatures are 
required for activation of the EGF-R kinase. These data are 
reminiscent of the earlier observations of Cohen et al.  who 
reported that activation of the EGF-R kinase in A431  mem- 
branes required incubation at 22"C and did not occur at 4"C 
(9).  We  also  found  that  EGF  treatment  of cytoskeletons 
prepared from untreated A431  cells did not activate EGF-R 
autophosphorylation in situ at either 4* or 37"C. This also is 
surprising,  given  the  extensive data  on  the  in  vitro  phos- 
phorylation of this protein. The significance of these findings 
is that the structural association of the EGF-R has a dramatic 
effect on the ability of EGF to stimulate the tyrosine kinase 
activity despite a functional binding domain. The structural 
association of the receptor may modulate both the activity of 
the enzyme and the availability of phosphorylation sites.  In 
the latter case the immobilization of the EGF-R may hinder 
its  access to  phosphorylation  sites  on  the  EGF-R  itself in 
intramolecular reactions. It is also possible that in untreated 
A431  cells the EGF-R is not in proximity to other EGF-R, 
which normally occurs as a consequence ofligand-stimulated 
receptor aggregation, permitting intermolecular reactions to 
occur. 
The relevance of the tyrosine kinase activity of the EGF-R 
to the biological effects of EGF is currently uncertain (12,  13). 
It is of interest that an immediate effect of EGF on A431 cells 
is a rapid change in cell surface morphology, with the devel- 
opment  of membrane  ruffles  and  lamellipodia,  subsiding 
within  10  min of EGF exposure (2,  3).  These changes are 
remarkably similar to those observed in Rous sarcoma virus- 
infected cells (64, 65), the transforming gene product of which 
is also a tyrosine kinase. The latter enzyme is at least in part 
associated with cytoskeletal elements on the cytoplasmic face 
of the plasma membrane (19, 66). 
The observation that the EGF-R is associated with struc- 
tural elements of the cell suggests that these structural inter- 
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R and may modulate its activity and substrate specificity. 
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